Semaglutide vs liraglutide treatment demonstrated superior weight loss at 1 year and 10% weight loss achievement among patients with obesity.

The U.K. is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with weight-loss treatment giant, Eli Lilly.

A study on the "real-world" effectiveness of weight loss drugs is set to measure the impact on the job prospects of people ...

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high ...

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding ...

We recently compiled a list of the 10 Most Promising Growth Stocks According to Hedge Funds. In this article, we are going to ...

A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

StudyFinds' Dr. Faith Coleman looks at the common mistakes patients make using GLP-1 agonists like Ozempic and Wegovy.

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

Even if your goal isn't weight loss or body recomposition, strength training provides many benefits that make it worth adding to your lifestyle, and it'll only improve your well-being in the long run.

However, it is rarely significant and does not amount to long-term weight loss. A person’s weight fluctuates throughout the day. This can vary depending on how much they eat and drink ...